July CPI, PPI and Cardinal Health Anchor Week Ahead
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- July CPI (Wednesday) and PPI (Thursday) anchor the week, with economists expecting 3.4% YoY headline CPI, 2.5% core CPI, 0.1% MoY headline PPI, and 0.3% core PPI per FactSet consensus.
- The Federal Reserve is openly split on AI capex's inflation impact: Governor Lisa Cook cited 'significant price increases for chips, other high-tech equipment, software, and utilities' and said she's 'prepared to act' on a rate hike, while Chair Kevin Warsh argues AI-driven productivity will eventually keep inflation low.
- Friday's July nonfarm payrolls missed badly — a 23,000-job loss against a Dow Jones consensus of +83,000 — though unemployment ticked down to 4.1% and wage inflation softened, giving the Fed cover to hold in September.
- Cardinal Health reports fiscal Q4 2026 Tuesday morning with LSEG consensus of $65.03B revenue and $2.42 EPS; the stock sits within 1.5% of its all-time high, and peers Cencora and McKesson beat and raised full-year guidance last week.
- Cardinal's specialty pharma and nuclear medicine units are key focus areas — GE Healthcare posted double-digit revenue growth for Cardinal-made Alzheimer's diagnostic Vizamyl in the June quarter, and momentum for Eli Lilly's Kisunla is driving demand.
- Treasury Secretary Scott Bessent said early last week that an Iran deal 'may be coming,' but the news never materialized, leaving markets needing further confirmation to sustain the Bessent-fueled optimism.
- Existing home sales (Tuesday) and July retail sales (Friday) round out the economic calendar, with retail sales the more market-relevant read on whether consumer resilience is holding up against rising prices.
Why it matters: Investors enter the week confronting a Fed divided on the single biggest driver of forward inflation — AI infrastructure spending — while Friday's stunning 23,000-job loss versus expectations for an 83,000 gain complicates the September rate calculus. Cardinal Health's fiscal 2027 guidance will set the bar for drug-distribution peers after Cencora and McKesson already raised, and CPI's energy-component signal will determine whether the Fed can look past the AI capex debate.
Ask SkimNews
